Literature DB >> 2540656

Cervical dysplasia and human papillomavirus.

J A Carmichael1, P D Maskens.   

Abstract

Evidence suggests a link between human papillomavirus infections and cervical dysplasia-carcinoma. This has led to the recommendation that when human papillomavirus infections are identified on the cervix, especially in association with dysplasia, these patients should have colposcopic assessment and treatment. The natural history of cervical human papillomavirus infections, particularly when associated with mild or moderate dysplasia, is not clear. To assess this question, 235 women with mild to moderate cervical dysplasia associated with a human papillomavirus infection were prospectively evaluated at 6-month intervals by the Colposcopy Clinic. This review suggests that mild to moderate cervical dysplasia associated with human papillomavirus infection eventually spontaneously disappears or, at worse, lingers on over many months in a mild to moderate form. These observations do not support the current popular practice of treating all mild to moderate cervical dysplasias associated with human papillomavirus infection or cervical human papillomavirus infection not associated with dysplastic lesions.

Entities:  

Mesh:

Year:  1989        PMID: 2540656     DOI: 10.1016/0002-9378(89)90310-4

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  4 in total

Review 1.  Report of a National Workshop on Screening for Cancer of the Cervix.

Authors:  A B Miller; G Anderson; J Brisson; J Laidlaw; N Le Pitre; P Malcolmson; P Mirwaldt; G Stuart; W Sullivan
Journal:  CMAJ       Date:  1991-11-15       Impact factor: 8.262

Review 2.  Human papillomavirus infection, cervical cancer and the less explored role of trace elements.

Authors:  Anne Boyina Sravani; Vivek Ghate; Shaila Lewis
Journal:  Biol Trace Elem Res       Date:  2022-04-25       Impact factor: 3.738

3.  Periodic health examination, 1995 update: 1. Screening for human papillomavirus infection in asymptomatic women. Canadian Task Force on the Periodic Health Examination.

Authors:  K Johnson
Journal:  CMAJ       Date:  1995-02-15       Impact factor: 8.262

4.  A randomized, double-blind, placebo-controlled trial of 5-fluorouracil for the treatment of cervicovaginal human papillomavirus.

Authors:  M M Holmes; S H Weaver; S T Vermillion
Journal:  Infect Dis Obstet Gynecol       Date:  1999
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.